The Medicines Company (MDCO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
40.01+0.23 (+0.58%)
As of 2:51 PM EDT. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close39.78
Bid40.01 x 100
Ask40.03 x 100
Day's Range39.40 - 40.21
52wk Range27.50 - 43.00
1y Target EstN/A
Market Cap2.78B
P/E Ratio (ttm)-12.44
Avg Vol (3m)847,215
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • The Medicines Co. to Get BARDA Funding for Infection Drugs
    Zacks6 days ago

    The Medicines Co. to Get BARDA Funding for Infection Drugs

    The Medicines Company (MDCO) announced a new strategic partnership with the Biomedical Advanced Research and Development Authority under which the company will receive funding for developing of new infection drug.

  • Accesswire6 days ago

    Blog Coverage Medicines Company in a Strategic Partnership with BARDA to Develop a New Range of Antibiotics

    LONDON, UK / ACCESSWIRE / September 22, 2016 / Active Wall St. blog coverage looks at the headline from The Medicines Company (NASDAQ: MDCO ) as the company announced on September 21, 2016, that the U.S. ...

  • Reuters7 days ago

    U.S. to invest in Medicines Co, Roche antibiotics development

    The Medicines Co on Wednesday said it will receive up to $132 million in U.S. government funding for development of new antibiotics to fight drug-resistant infections, seen by health officials as a critically important need. Under terms of the agreement, the company said it will receive $32 million in initial funding from BARDA, the Biomedical Advanced Research and Development Authority, a division of the U.S. Department of Health and Human Services. Medicines Co would be eligible to receive up to an additional $100 million over five years if BARDA exercises all of its options to extend the partnership, the company said.